New England Research & Management, Inc.
Source: SEC Form 13F · as of Mar 2026New England Research & Management, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $36.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$36.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 28,813 | $7.0M |
| ABBVAbbVie Inc. | 25,510 | $5.5M |
| AMGNAMGEN INC | 9,810 | $3.5M |
| MRKMerck & Co., Inc. | 26,529 | $3.2M |
| LLYELI LILLY & Co | 3,153 | $2.9M |
| ZTSZoetis Inc. | 20,391 | $2.4M |
| ABTABBOTT LABORATORIES | 21,874 | $2.2M |
| IDXXIDEXX LABORATORIES INC /DE | 3,800 | $2.1M |
| GILDGILEAD SCIENCES, INC. | 11,070 | $1.5M |
| INCYIncyte Corp. | 16,350 | $1.5M |
| PFEPFIZER INC | 46,910 | $1.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,600 | $714K |
| UTHRUNITED THERAPEUTICS Corp | 1,130 | $670K |
| AZNASTRAZENECA PLC | 3,298 | $650K |
| IQVIQVIA Holdings Inc. | 2,880 | $491K |
| REGNREGENERON PHARMACEUTICALS, INC. | 575 | $444K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.